This study provides novel and convincing evidence that both dopamine D1 and D2 expressing neurons in the nucleus accumbens shell are crucial for the expression of cue-guided action selection, a ...

The Manipur government has come up with a three-phase plan to ensure internally displaced persons can return home safely to rebuild and restart their lives in peace, Chief Secretary Prashant Kumar ...

To access Veo 3 in India, users must subscribe to the AI Pro plan via the Gemini app (available on Android and iOS). The AI Pro subscription is priced at Rs 1,999 per month.

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected later.

ITI Limited signs agreements with BSNL for BharatNet Phase-3 Project, totaling ₹6,956 crore, with a challenging yet promising future.

This Phase 3 trial validates telehealth as a scalable, cost-effective model for neurorehabilitation, and positions VSee as the go-to platform for the next wave of value-based virtual care that ...

The U.S. Army Corps of Engineers announced that the remaining Phase 3 construction options have been awarded for the new lock project at the Soo Locks.

With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 ...

Google's $20 Pro plan now includes Veo 3 Fast, letting users create high-quality AI videos daily. It's an affordable game-changer in video generation tech.

CHICAGO — Positive interpretations of randomized phase 3 oncology trials often are based on improvements in unvalidated alternative endpoints, findings presented at ASCO Annual Meeting showed.

PALISADE-3 and PALISADE-4 are multi-center, randomized, double-blind, placebo-controlled Phase 3 trials designed similarly to PALISADE-2 to evaluate the efficacy, safety, and tolerability of the acute ...

Phase 3 trial shows vepdegestrant improves progression-free survival in metastatic breast cancer patients with ESR1 mutations versus fulvestrant. Quiver AI Summary Arvinas, Inc. and Pfizer, Inc ...